Published in Stroke on March 01, 1988
Blood Pressure Reduction in the Acute Phase of an Ischemic Stroke Does Not Improve Short- or Long-Term Dependency or Mortality: A Meta-Analysis of Current Literature. Medicine (Baltimore) (2015) 0.75
What have drugs to offer the patient with acute stroke? Br J Clin Pharmacol (1992) 0.75
Blood pressure management in acute stroke. Stroke Vasc Neurol (2016) 0.75
Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology (2000) 4.13
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology (1998) 3.62
The Stroke Outcomes and Neuroimaging of Intracranial Atherosclerosis (SONIA) trial. Neurology (2007) 3.24
Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group. N Engl J Med (1999) 2.82
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke (2001) 2.65
Significance of hyperintense vessels on FLAIR MRI in acute stroke. Neurology (2000) 2.27
Lack of clinical significance of early ischemic changes on computed tomography in acute stroke. JAMA (2001) 2.24
Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke (1999) 2.17
A modified National Institutes of Health Stroke Scale for use in stroke clinical trials: preliminary reliability and validity. Stroke (2001) 2.16
The Warfarin-Aspirin Symptomatic Intracranial Disease Study. Neurology (1995) 2.10
Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology (2002) 2.02
Ataxic hemiparesis: critical appraisal of a lacunar syndrome. Stroke (1998) 1.98
Vasospasm and thrombus formation as possible mechanisms of stroke related to alkaloidal cocaine. Stroke (1995) 1.91
Occipital lobe seizures as the major clinical manifestation of reversible posterior leukoencephalopathy syndrome: magnetic resonance imaging findings. Epilepsia (1998) 1.87
Cerebrovascular complications of Fabry's disease. Ann Neurol (1996) 1.78
A model to predict the histopathology of human stroke using diffusion and T2-weighted magnetic resonance imaging. Stroke (1995) 1.75
Low brain magnesium in migraine. Headache (1989) 1.70
Pilot study of functional MRI to assess cerebral activation of motor function after poststroke hemiparesis. Stroke (1998) 1.55
Time course of ADCw changes in ischemic stroke: beyond the human eye! Stroke (1998) 1.54
Role of anticardiolipin antibodies in young persons with migraine and transient focal neurologic events: a prospective study. Neurology (1998) 1.51
Predicting prognosis after stroke: a placebo group analysis from the National Institute of Neurological Disorders and Stroke rt-PA Stroke Trial. Neurology (2000) 1.48
Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Circulation (2001) 1.48
"Normal-pressure" hydrocephalus. Relationship of clinical and radiographic findings to improvement following shunt surgery. JAMA (1976) 1.47
Paroxysmal choreoathetosis due to hypoglycemia. Arch Neurol (1984) 1.45
Spectrum of patients with EMG features of polyradiculopathy without neuropathy. Muscle Nerve (1990) 1.40
Computerized axial transverse tomography in cerebrovascular disease. Neurology (1976) 1.39
Clinical deterioration following improvement in the NINDS rt-PA Stroke Trial. Stroke (2001) 1.38
Predictors of good outcome after intravenous tPA for acute ischemic stroke. Neurology (2001) 1.37
Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older : the tPA stroke survey experience. Stroke (2000) 1.35
Cocaine and stroke. Stroke (1988) 1.27
Cerebellar infarction. Clinical and anatomic observations in 66 cases. Stroke (1993) 1.26
Methicillin distribution in serum and extravascular fluid and its relevance to normal and damaged heart valves. Antimicrob Agents Chemother (1981) 1.22
Correlations of nuclear magnetic resonance imaging, computerized tomography, and clinical profiles in multiple sclerosis. Neurology (1986) 1.22
Urinary casts as an indicator of renal tubular damage in patients receiving aminoglycosides. Antimicrob Agents Chemother (1979) 1.21
Cocaine-associated intracranial hemorrhage: absence of vasculitis in 14 cases. Neurology (1996) 1.17
Changes in size of normal lateral ventricles during aging determined by computerized tomography. Neurology (1976) 1.17
Creatine use among young athletes. Pediatrics (2001) 1.17
Integration of pharmacokinetics and pharmacodynamics of methicillin in curative treatment of experimental endocarditis. J Antimicrob Chemother (1984) 1.15
The spectrum of neurologic disease associated with antiphospholipid antibodies. Lupus anticoagulants and anticardiolipin antibodies. Arch Neurol (1987) 1.14
Cerebral venous thrombosis and anticardiolipin antibodies. Stroke (1997) 1.13
Warfarin vs aspirin for symptomatic intracranial stenosis: subgroup analyses from WASID. Neurology (2006) 1.13
Finding the most powerful measures of the effectiveness of tissue plasminogen activator in the NINDS tPA stroke trial. Stroke (2000) 1.12
Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA Stroke Survey Group. Neurology (1999) 1.10
High-resolution fluorodeoxyglucose positron emission tomography shows both global and regional cerebral hypometabolism in multiple sclerosis. J Neuroimaging (1998) 1.09
Crack-associated stroke. Neurology (1987) 1.09
Thrombolytic therapy of acute ischemic stroke during pregnancy. Neurology (2006) 1.08
Pursuing the promise of an information-age health care system. Health Aff (Millwood) (1999) 1.08
Rate of methicillin penetration into normal heart valve and experimental endocarditis lesions. Antimicrob Agents Chemother (1982) 1.08
Stroke and the antiphospholipid syndrome: consensus meeting Taormina 2002. Lupus (2003) 1.04
Cerebral venous infarctions presenting as enhancing space-occupying lesions: MRI findings. J Neuroimaging (1998) 1.03
Subcortical arteriosclerotic encephalopathy (Binswanger's disease). Computed tomographic, nuclear magnetic resonance, and clinical correlations. Arch Neurol (1985) 1.03
Silent brain lesions in patients with isolated idiopathic optic neuritis. A clinical and nuclear magnetic resonance imaging study. Arch Neurol (1986) 1.02
Cranial magnetic resonance imaging findings in bacterial endocarditis: the neuroimaging spectrum of septic brain embolization demonstrated in twelve patients. J Neuroimaging (1999) 1.00
Large cerebral vessel occlusive disease in systemic lupus erythematosus. Neurology (1994) 0.98
Possible association of ischemic stroke with phentermine. Stroke (1993) 0.98
Impact of triplicate prescription program on psychotropic prescribing patterns in long-term care facilities. Ann Pharmacother (1992) 0.98
Magnetic resonance imaging findings in acute cerebellitis. Clin Imaging (1998) 0.97
Intramedullary spinal sarcoidosis: clinical and magnetic resonance imaging characteristics. Neurology (1993) 0.97
Factors associated with early presentation of acute stroke. Stroke (1993) 0.96
Pharmacokinetics and pharmacodynamics of midazolam after intranasal administration. J Clin Pharmacol (1997) 0.95
Fluid-attenuated inversion-recovery MR imaging in acute and subacute cerebral intraventricular hemorrhage. AJNR Am J Neuroradiol (1999) 0.94
Principles of antibiotic tissue penetration and guidelines for pharmacokinetic analysis. Med Clin North Am (1982) 0.94
Migraine-related stroke in the context of the International Headache Society classification of head pain. Arch Neurol (1990) 0.93
Masson's tumor of the kidney: a new renal lesion. J Urol (1990) 0.93
Cerebrovascular ischemia associated with lupus anticoagulant. Stroke (1987) 0.92
Cerebral venous thrombosis with lupus anticoagulants. Report of two cases. Stroke (1987) 0.92
Low brain magnesium in migraine. Headache (1989) 0.91
In vivo 31P NMR profiles of Alzheimer's disease and multiple subcortical infarct dementia. Neurology (1989) 0.91
Lipid-soluble and water-soluble beta-blockers. Comparison of the central nervous system depressant effect. Arch Intern Med (1987) 0.90
Hypomagnesemia and ventricular tachycardia: a complication of ulcerative colitis and parenteral hyperalimentation in a nondigitalized noncardiac patient. Chest (1982) 0.90
Non-stroke neurological syndromes associated with antiphospholipid antibodies: evaluation of clinical and experimental studies. Lupus (2003) 0.89
Stroke in patients with fusiform vertebrobasilar aneurysms. Neurology (1989) 0.88
Autopsy correlations of computerized tomography: experience with 6,000 CT scans. Neurology (1976) 0.88
Apolipoprotein E phenotype and the efficacy of intravenous tissue plasminogen activator in acute ischemic stroke. Ann Neurol (2001) 0.87
Pharmacokinetics of capacity-limited tissue distribution of methicillin in rabbits. J Pharm Sci (1984) 0.87
Magnetic resonance spectroscopy in cerebral ischemia. Neurol Clin (1992) 0.87
Altered brain energy metabolism in demented patients with multiple subcortical ischemic lesions. Working hypotheses. Arch Neurol (1993) 0.87
Stroke after bone marrow transplantation: frequency, aetiology and outcome. Brain (2001) 0.86
Gray matter enhancement: a computerized tomographic sign of cerebral hypoxia. Neurology (1980) 0.86
Ventricular arrhythmias during exercise testing: mechanism, response to coronary bypass surgery and prognostic significance. Am J Cardiol (1984) 0.85
The relative antihistaminic and psychomotor effects of hydroxyzine and cetirizine. Clin Pharmacol Ther (1987) 0.84
Nuclear magnetic resonance imaging in patients with stroke. Semin Neurol (1986) 0.84
Intravenous thrombolysis for acute stroke. Neurology (1997) 0.84
Central nervous system lupus erythematosus: the value of magnetic resonance imaging. J Rheumatol (1988) 0.84
Recurrent stroke associated with thymoma and anticardiolipin antibodies. Arch Neurol (1987) 0.84
Distribution of the 72-kd heat-shock protein as a function of transient focal cerebral ischemia in rats. Stroke (1992) 0.83
Cerebral blood flow changes with enalapril. Pharmacotherapy (1992) 0.83
Adhesive glycoproteins CD11a and CD18 are upregulated in the leukocytes from patients with ischemic stroke and transient ischemic attacks. J Neurol Sci (1995) 0.82
Altitudinal hemianopia caused by occipital infarctions. Clinical and computerized tomographic correlations. Arch Neurol (1984) 0.82
Polyradiculopathy in sarcoidosis. Muscle Nerve (1999) 0.82
Attenuation of risperidone-induced hyperprolactinemia with the addition of aripiprazole. J Clin Pharm Ther (2009) 0.82
Tissue plasminogen activator for acute ischemic stroke in patients with unruptured cerebral aneurysms. J Stroke Cerebrovasc Dis (2013) 0.81
Serum concentrations of propranolol and migraine prophylaxis. Arch Neurol (1984) 0.81
Antiphospholipid-protein antibodies and ischemic stroke: not just cardiolipin any more. Stroke (1998) 0.81
Acute elevation and recovery of intracellular [Mg2+] following human focal cerebral ischemia. Neurology (1993) 0.81
Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology (1989) 0.81